Cenduit to Showcase its Advanced IRT Solutions for Patient and Drug Management at Partnerships in Clinical Trials Europe

DURHAM, NC, UNITED STATES - Nov 14, 2016 - Cenduit, a joint venture between QuintilesIMS and Thermo Fisher Scientific, is showcasing its solutions and expertise as the largest interactive response technology (IRT) specialist in the world at Partnerships in Clinical Trials Europe, Nov. 16-17 in Vienna, Austria.  

“This conference is a great platform for industry leaders to come together with a common goal of accelerating clinical development and improving clinical trials,” said Stacy Gletzakos, global head of business development, account management and marketing, Cenduit. “Patients are at the forefront of what we do and we look forward to demonstrating how Cenduit’s solutions can enhance patient and drug management, while also reducing costs in clinical trials."

Attendees are invited to stop by the Cenduit booth, #325, to learn how the company’s IRT solutions can help sponsors increase efficiencies and reduce costs to get their product to market faster.

WHO:     Cenduit attendees include:

• Stacy Gletzakos, global head of business development, account management and marketing, Cenduit
• David Horsley, business development director, Cenduit
• Laetitia Soudanas, business development executive, Cenduit

WHEN:   Nov. 16, 2016, 7:30 a.m. to Nov. 17, 2016, 4:30 p.m.

WHERE:  Reed Messe Wien Congress Center      
              Messepl. 1, 1020 Wien
              Vienna, Austria